Nzwakie Mosery
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Nzwakie Mosery has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
- Christina Psaros
Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, USA
6 shared publications - Amelia M. Stanton
Department of Psychological & Brain Sciences, Boston University, Boston, USA
4 shared publications - Jennifer A. Smit
Wits MatCH Research Unit, Department of Obstetrics and Gynaecology, University of the Witwatersrand Johannesburg, GP, South Africa
4 shared publications - Steven A. Safren
Department of Psychology, University of Miami, Coral Gables, FL
4 shared publications - Abigail Harrison
Department of Behavioral and Social Sciences, Brown University School of Public Health, Providence, USA
2 shared publications Bongeka Qiya
Wits MRU (Maternal, Adolescent, and Child Health Research Unit), Department of Obstetrics and Gynaecology, Faculty of Health Sciences, University of the Witwatersrand), Durban, South Africa
2 shared publications
Latest Publications
- Open Access
- 25 June 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e79777
A Resiliency Intervention to Support Nurses Engaged in the Provision of HIV Care in KwaZulu-Natal, South Africa: Protocol for a Pilot Randomized Controlled Trial
Background: South Africa has the largest HIV epidemic in the world; in KwaZulu-Natal Province, over 40.8% of adults aged 15 years and older are living with HIV. Despite this, South Africa is home to only 3% of the world’s health care workers. Nurses constitute the largest group of providers in South Africa and experience high levels of burnout, which can contribute to negative patient outcomes for people living with HIV, including reduced treatment adherence. Nurse-centered interventions that offset these effects are urgently needed. Objective: This study aims to test the feasibility and acceptability of an adapted resiliency intervention (Stress Management and Resiliency Training-Relaxation Response Resiliency Program) for professional nurses who provide care for people living with HIV in South Africa. Methods: In phase 1 (Human Research Ethics Committee [Medical] of the University of the Witwatersrand [220813, Johannesburg, South Africa] and the Massachusetts General Brigham Institutional Review Board [2022P002765, Boston, Massachusetts, United States]), we conducted 3 focus group discussions to solicit feedback on the lived experiences of stress, sources of stress, impact on job functioning, coping strategies, the proposed intervention, and recruitment strategies for nurses. These data informed adaptations to the intervention. In phase 2 (Human Research Ethics Committee [240106, Johannesburg, South Africa]; Massachusetts General Brigham Institutional Review Board [2024P001407, Boston, Massachusetts, United States]), we conducted a small proof-of-concept study (N=8) with preintervention and postintervention assessments, 6 intervention sessions with a nurse interventionist, and a qualitative exit interview. Following appropriate adaptations, we conducted a pilot randomized controlled trial (N=60) in which participants were randomized to the intervention or the control condition. The control condition received a one-time, 90-minute didactic stress management session. The intervention condition consisted of two 4-hour group skills-based sessions on the relaxation response, components of stress, recuperative sleep, mindful awareness, resilience, and social support. Sessions included practice-based exercises and videos to complement the intervention materials. Baseline, posttreatment (intervention only), and follow-up assessments, as well as qualitative exit interviews (n=15, intervention only), were conducted. Primary outcomes are feasibility (number screened, eligible, and enrolled; the number of treatment sessions and assessments completed in the intervention arm; assessment duration; and reasons for declining enrollment and prematurely leaving the trial) and acceptability (Client Satisfaction Questionnaire-8 and qualitative data). Results: The project is funded by the National Institute of Mental Health (R34MH126753; September 2022). As of October 2025, we have completed both the proof-of-concept study (n=8; February 2025) and the pilot randomized controlled trial (n=60; August 2025). Data analysis is in progress and is expected to be completed in August 2026. Conclusions: Structural changes are needed to ensure the well-being of health care providers; however, given that structural changes take time, money, and political capital to execute, we must develop interventions to support providers’ mental health while advocating for systematic change.
- 25 June 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e79777
Open AccessA Resiliency Intervention to Support Nurses Engaged in the Provision of HIV Care in KwaZulu-Natal, South Africa: Protocol for a Pilot Randomized Controlled Trial
Background: South Africa has the largest HIV epidemic in the world; in KwaZulu-Natal Province, over 40.8% of adults aged 15 years and older are living with HIV. Despite this, South Africa is home to only 3% of the world’s health care workers. Nurses constitute the largest group of providers in South Africa and experience high levels of burnout, which can contribute to negative patient outcomes for people living with HIV, including reduced treatment adherence. Nurse-centered interventions that offset these effects are urgently needed. Objective: This study aims to test the feasibility and acceptability of an adapted resiliency intervention (Stress Management and Resiliency Training-Relaxation Response Resiliency Program) for professional nurses who provide care for people living with HIV in South Africa. Methods: In phase 1 (Human Research Ethics Committee [Medical] of the University of the Witwatersrand [220813, Johannesburg, South Africa] and the Massachusetts General Brigham Institutional Review Board [2022P002765, Boston, Massachusetts, United States]), we conducted 3 focus group discussions to solicit feedback on the lived experiences of stress, sources of stress, impact on job functioning, coping strategies, the proposed intervention, and recruitment strategies for nurses. These data informed adaptations to the intervention. In phase 2 (Human Research Ethics Committee [240106, Johannesburg, South Africa]; Massachusetts General Brigham Institutional Review Board [2024P001407, Boston, Massachusetts, United States]), we conducted a small proof-of-concept study (N=8) with preintervention and postintervention assessments, 6 intervention sessions with a nurse interventionist, and a qualitative exit interview. Following appropriate adaptations, we conducted a pilot randomized controlled trial (N=60) in which participants were randomized to the intervention or the control condition. The control condition received a one-time, 90-minute didactic stress management session. The intervention condition consisted of two 4-hour group skills-based sessions on the relaxation response, components of stress, recuperative sleep, mindful awareness, resilience, and social support. Sessions included practice-based exercises and videos to complement the intervention materials. Baseline, posttreatment (intervention only), and follow-up assessments, as well as qualitative exit interviews (n=15, intervention only), were conducted. Primary outcomes are feasibility (number screened, eligible, and enrolled; the number of treatment sessions and assessments completed in the intervention arm; assessment duration; and reasons for declining enrollment and prematurely leaving the trial) and acceptability (Client Satisfaction Questionnaire-8 and qualitative data). Results: The project is funded by the National Institute of Mental Health (R34MH126753; September 2022). As of October 2025, we have completed both the proof-of-concept study (n=8; February 2025) and the pilot randomized controlled trial (n=60; August 2025). Data analysis is in progress and is expected to be completed in August 2026. Conclusions: Structural changes are needed to ensure the well-being of health care providers; however, given that structural changes take time, money, and political capital to execute, we must develop interventions to support providers’ mental health while advocating for systematic change.
- Open Access
Defining a person-centered conceptual model to inform measurement of contraception’s effects on the menstrual cycle
Objective: To address the need for improved measurement of the ways contraception impacts the baseline menstrual cycle (i.e., contraceptive-induced menstrual changes; CIMCs) by assembling an interdisciplinary, global research collective to rigorously develop a person-centered measure for CIMCs in multiple languages. As the first step, this paper reports on our conceptual model development, which is the foundation for ongoing measure development. Study design: We conducted 18 focus groups with 106 people experiencing CIMCs while using hormonal or intrauterine contraception in Durban, South Africa, Santo Domingo, Dominican Republic, and Portland Oregon, United States. We used a virtual affinity mapping approach to analyze qualitative data, which was the basis of our conceptual model along with relevant theory and related models in the literature. Results: The conceptual model of experiences with CIMCs depicts the baseline menstrual cycle, including CIMCs and conceptually-linked effects and the impacts and perceptions of those CIMCs. We found key domains of changes in pain, bleeding volume, bleeding patterns, and characteristics of blood. Conclusion: Our CIMC conceptual model will inform development of a measure with evidence of validation across three language and global contexts. Adoption of a person-centered, standardized CIMC measurement across trials will improve knowledge and decision-making between methods. Implications: Defining an evidenced-based conceptual model for CIMCs expands our understanding of how contraceptive users experience and understand menstruation and CIMCs. We can use this model to improve and standardize measurement of CIMCs.
Open AccessDefining a person-centered conceptual model to inform measurement of contraception’s effects on the menstrual cycle
Objective: To address the need for improved measurement of the ways contraception impacts the baseline menstrual cycle (i.e., contraceptive-induced menstrual changes; CIMCs) by assembling an interdisciplinary, global research collective to rigorously develop a person-centered measure for CIMCs in multiple languages. As the first step, this paper reports on our conceptual model development, which is the foundation for ongoing measure development. Study design: We conducted 18 focus groups with 106 people experiencing CIMCs while using hormonal or intrauterine contraception in Durban, South Africa, Santo Domingo, Dominican Republic, and Portland Oregon, United States. We used a virtual affinity mapping approach to analyze qualitative data, which was the basis of our conceptual model along with relevant theory and related models in the literature. Results: The conceptual model of experiences with CIMCs depicts the baseline menstrual cycle, including CIMCs and conceptually-linked effects and the impacts and perceptions of those CIMCs. We found key domains of changes in pain, bleeding volume, bleeding patterns, and characteristics of blood. Conclusion: Our CIMC conceptual model will inform development of a measure with evidence of validation across three language and global contexts. Adoption of a person-centered, standardized CIMC measurement across trials will improve knowledge and decision-making between methods. Implications: Defining an evidenced-based conceptual model for CIMCs expands our understanding of how contraceptive users experience and understand menstruation and CIMCs. We can use this model to improve and standardize measurement of CIMCs.
- Open Access
- 18 November 2025
- Published by Springer Nature in AIDS and Behavior
- Vol. 30 (4) , 1172-1185
Streamlining Stigma Measurement: Validation and Abridgment of the HIV Stigma Scale for Pregnant Women Living with HIV in South Africa
The HIV Stigma Scale (HSS) is a 40-item psychometrically sound measure capturing four domains of perceived stigma. A 25-item version has been validated in South India. However, the HSS has not been validated among pregnant women with HIV (WWH) in South Africa, a population facing significant stigma. Moreover, they could benefit from the abridged measure to be more efficiently connected to related interventions. Analyzing data from a sample of pregnant WWH ( N = 472) recruited from an antenatal care clinic in eThekweni, Kwazulu-Natal Province, we: (1) conducted confirmatory factor analyses (CFA) to determine if the 4-factor structure of the original 40-item scale holds for the 25-item version in this sample; (2) further shortened the 25-item version using data-driven item reduction, and (3) conducted a comprehensive psychometric evaluation on the abridged version that included internal consistency and construct validity. The CFA confirmed a four-factor structure of the 25-item scale (CFI = 1.00, RMSEA = 0.03, SRMR = 0.04) in pregnant WWH. For model identification, we retained three items per factor. CFA of this 12-item version revealed model fit (CFI = 1.00, RMSEA = 0.01, SRMR = 0.03). All four subscales in the abridged scale showed satisfactory internal consistency (Cronbach’s α > 0.80) and construct validity. This is the first study validating the HSS among pregnant WWH in an HIV-endemic setting and developing a psychometrically robust 12-item version, maintaining the four-factor structure of the original measure. Clinically, the abridged HSS enables more efficient screening and reduces participant burden, which could improve reporting and early implementation of stigma reduction interventions in resource-limited settings.
- 18 November 2025
- Published by Springer Nature in AIDS and Behavior
- Vol. 30 (4) , 1172-1185
Open AccessStreamlining Stigma Measurement: Validation and Abridgment of the HIV Stigma Scale for Pregnant Women Living with HIV in South Africa
The HIV Stigma Scale (HSS) is a 40-item psychometrically sound measure capturing four domains of perceived stigma. A 25-item version has been validated in South India. However, the HSS has not been validated among pregnant women with HIV (WWH) in South Africa, a population facing significant stigma. Moreover, they could benefit from the abridged measure to be more efficiently connected to related interventions. Analyzing data from a sample of pregnant WWH ( N = 472) recruited from an antenatal care clinic in eThekweni, Kwazulu-Natal Province, we: (1) conducted confirmatory factor analyses (CFA) to determine if the 4-factor structure of the original 40-item scale holds for the 25-item version in this sample; (2) further shortened the 25-item version using data-driven item reduction, and (3) conducted a comprehensive psychometric evaluation on the abridged version that included internal consistency and construct validity. The CFA confirmed a four-factor structure of the 25-item scale (CFI = 1.00, RMSEA = 0.03, SRMR = 0.04) in pregnant WWH. For model identification, we retained three items per factor. CFA of this 12-item version revealed model fit (CFI = 1.00, RMSEA = 0.01, SRMR = 0.03). All four subscales in the abridged scale showed satisfactory internal consistency (Cronbach’s α > 0.80) and construct validity. This is the first study validating the HSS among pregnant WWH in an HIV-endemic setting and developing a psychometrically robust 12-item version, maintaining the four-factor structure of the original measure. Clinically, the abridged HSS enables more efficient screening and reduces participant burden, which could improve reporting and early implementation of stigma reduction interventions in resource-limited settings.
- Open Access
- 27 June 2025
- Published by JMIR Publications Inc. in JMIR Preprints
A Resiliency Intervention to Support Nurses Engaged in the Provision of HIV Care in KwaZulu-Natal, South Africa: Protocol for a pilot Randomized Control Trial (Preprint)
UNSTRUCTURED South Africa (SA) has the largest HIV epidemic in the world; in KwaZulu-Natal (KZN) Province, over 40.8% of adults over 15 are living with HIV. Despite this, SA is home to only 3% of the world’s healthcare workers. Nurses constitute the largest group of providers in SA and experience high levels of burnout, which can contribute to negative patient outcomes for persons living with HIV (PWH), including reduced treatment adherence. Patient-provider relationships are the gateway to engagement and retention in HIV care yet relationships can be compromised in overburdened nurses. Nurse-centered interventions that offset these effects are urgently needed. The purpose of this study is to pilot an adapted resiliency-based mind-body intervention (the Relaxation Response Resiliency Program; the 3RP) for nurses that provide care for PWH in the public sector in SA. In Phase 1 [NIH Grant Number: R34MH131426; HREC Ethics Reference Number: 220813], we conducted focus group discussions to solicit feedback on: the role of culture and perceptions of stress; the lived experiences of stress; sources of stress (e.g., occupational, trauma-related); how stress impacts job functioning (specifically patient care); current coping strategies; and the proposed intervention modules (content, number of sessions, session duration, program length, use of coaches, mode of delivery (e.g., virtual, in-person, hybrid approaches), etc.). In this Phase 2, we will conduct a small proof-of-concept study (N = 8-10), followed by a randomized pilot (N = 60), of nurses that care for PWH in the public sector in SA to test the feasibility and acceptability of the adapted intervention.
- 27 June 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessA Resiliency Intervention to Support Nurses Engaged in the Provision of HIV Care in KwaZulu-Natal, South Africa: Protocol for a pilot Randomized Control Trial (Preprint)
UNSTRUCTURED South Africa (SA) has the largest HIV epidemic in the world; in KwaZulu-Natal (KZN) Province, over 40.8% of adults over 15 are living with HIV. Despite this, SA is home to only 3% of the world’s healthcare workers. Nurses constitute the largest group of providers in SA and experience high levels of burnout, which can contribute to negative patient outcomes for persons living with HIV (PWH), including reduced treatment adherence. Patient-provider relationships are the gateway to engagement and retention in HIV care yet relationships can be compromised in overburdened nurses. Nurse-centered interventions that offset these effects are urgently needed. The purpose of this study is to pilot an adapted resiliency-based mind-body intervention (the Relaxation Response Resiliency Program; the 3RP) for nurses that provide care for PWH in the public sector in SA. In Phase 1 [NIH Grant Number: R34MH131426; HREC Ethics Reference Number: 220813], we conducted focus group discussions to solicit feedback on: the role of culture and perceptions of stress; the lived experiences of stress; sources of stress (e.g., occupational, trauma-related); how stress impacts job functioning (specifically patient care); current coping strategies; and the proposed intervention modules (content, number of sessions, session duration, program length, use of coaches, mode of delivery (e.g., virtual, in-person, hybrid approaches), etc.). In this Phase 2, we will conduct a small proof-of-concept study (N = 8-10), followed by a randomized pilot (N = 60), of nurses that care for PWH in the public sector in SA to test the feasibility and acceptability of the adapted intervention.
- Open Access
- 4 May 2022
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 6 (5) , e34262
Demonstration and Acceptability of a Safer Conception Intervention for Men With HIV in South Africa: Pilot Cohort Study
Background: Many men with HIV (MWH) want to have children. HIV viral suppression minimizes sexual HIV transmission risks while allowing for conception and optimization of the health of men, their partners, and their infants. Objective: This study developed and evaluated the feasibility and acceptability of an intervention to promote serostatus disclosure, antiretroviral therapy (ART) uptake and adherence, and viral suppression among MWH who want to have children in South Africa. Methods: We developed a safer conception intervention (Sinikithemba Kwabesilisa or We give hope to men) to promote viral suppression via ART uptake and adherence, HIV serostatus disclosure, and other safer conception strategies for MWH in South Africa. Through 3 counseling and 2 booster sessions over 12 weeks, we offered education on safer conception strategies and aided participants in developing a safer conception plan. We recruited MWH (HIV diagnosis known for >1 month), not yet accessing ART or accessing ART for <3 months, in a stable partnership with an HIV-negative or unknown-serostatus woman, and wanting to have a child in the following year. We conducted an open pilot study to evaluate acceptability based on patient participation and exit interviews and feasibility based on recruitment and retention. In-depth exit interviews were conducted with men to explore intervention acceptability. Questionnaires collected at baseline and exit assessed disclosure outcomes; CD4 and HIV-RNA data were used to evaluate preliminary impacts on clinical outcomes of interest. Results: Among 31 eligible men, 16 (52%) enrolled in the study with a median age of 29 (range 27-44) years and a median time-since-diagnosis of 7 months (range 1 month to 9 years). All identified as Black South African, with 56% (9/16) reporting secondary school completion and 44% (7/16) reporting full-time employment. Approximately 44% (7/16) of participants reported an HIV-negative (vs unknown-serostatus) partner. Approximately 88% (14/16) of men completed the 3 primary counseling sessions. In 11 exit interviews, men reported personal satisfaction with session content and structure while also suggesting that they would refer their peers to the program. They also described the perceived effectiveness of the intervention and self-efficacy to benefit. Although significance testing was not conducted, 81% (13/16) of men were taking ART at the exit, and 100% (13/13) of those on ART were virally suppressed at 12 weeks. Of the 16 men, 12 (75%) reported disclosure to pregnancy partners. Conclusions: These preliminary data suggest that safer conception care is acceptable to men and has the potential to reduce HIV incidence among women and their children while supporting men’s health. Approximately half of the men who met the screening eligibility criteria were enrolled. Accordingly, refinement to optimize uptake is needed. Providing safer conception care and peer support at the community level may help reach men. Trial Registration: ClinicalTrials.gov NCT03818984; https://clinicaltrials.gov/ct2/show/NCT03818984 International Registered Report Identifier (IRRID): RR2-https://doi.org/10.1007/s10461-017-1719-4
- 4 May 2022
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 6 (5) , e34262
Open AccessDemonstration and Acceptability of a Safer Conception Intervention for Men With HIV in South Africa: Pilot Cohort Study
Background: Many men with HIV (MWH) want to have children. HIV viral suppression minimizes sexual HIV transmission risks while allowing for conception and optimization of the health of men, their partners, and their infants. Objective: This study developed and evaluated the feasibility and acceptability of an intervention to promote serostatus disclosure, antiretroviral therapy (ART) uptake and adherence, and viral suppression among MWH who want to have children in South Africa. Methods: We developed a safer conception intervention (Sinikithemba Kwabesilisa or We give hope to men) to promote viral suppression via ART uptake and adherence, HIV serostatus disclosure, and other safer conception strategies for MWH in South Africa. Through 3 counseling and 2 booster sessions over 12 weeks, we offered education on safer conception strategies and aided participants in developing a safer conception plan. We recruited MWH (HIV diagnosis known for >1 month), not yet accessing ART or accessing ART for <3 months, in a stable partnership with an HIV-negative or unknown-serostatus woman, and wanting to have a child in the following year. We conducted an open pilot study to evaluate acceptability based on patient participation and exit interviews and feasibility based on recruitment and retention. In-depth exit interviews were conducted with men to explore intervention acceptability. Questionnaires collected at baseline and exit assessed disclosure outcomes; CD4 and HIV-RNA data were used to evaluate preliminary impacts on clinical outcomes of interest. Results: Among 31 eligible men, 16 (52%) enrolled in the study with a median age of 29 (range 27-44) years and a median time-since-diagnosis of 7 months (range 1 month to 9 years). All identified as Black South African, with 56% (9/16) reporting secondary school completion and 44% (7/16) reporting full-time employment. Approximately 44% (7/16) of participants reported an HIV-negative (vs unknown-serostatus) partner. Approximately 88% (14/16) of men completed the 3 primary counseling sessions. In 11 exit interviews, men reported personal satisfaction with session content and structure while also suggesting that they would refer their peers to the program. They also described the perceived effectiveness of the intervention and self-efficacy to benefit. Although significance testing was not conducted, 81% (13/16) of men were taking ART at the exit, and 100% (13/13) of those on ART were virally suppressed at 12 weeks. Of the 16 men, 12 (75%) reported disclosure to pregnancy partners. Conclusions: These preliminary data suggest that safer conception care is acceptable to men and has the potential to reduce HIV incidence among women and their children while supporting men’s health. Approximately half of the men who met the screening eligibility criteria were enrolled. Accordingly, refinement to optimize uptake is needed. Providing safer conception care and peer support at the community level may help reach men. Trial Registration: ClinicalTrials.gov NCT03818984; https://clinicaltrials.gov/ct2/show/NCT03818984 International Registered Report Identifier (IRRID): RR2-https://doi.org/10.1007/s10461-017-1719-4
- 8 March 2022
- Published by Springer Nature in International Journal of Behavioral Medicine
- Vol. 30 (1) , 62-76
Optimizing PMTCT Adherence by Treating Depression in Perinatal Women with HIV in South Africa: A Pilot Randomized Controlled Trial
Background South Africa (SA) has the greatest HIV prevalence in the world, with rates as high as 40% among pregnant women. Depression is a robust predictor of nonadherence to antiretroviral therapy (ART) and engagement in HIV care; perinatal depression may affect upwards of 47% of women in SA. Evidence-based, scalable approaches for depression treatment and ART adherence in this setting are lacking. Method Twenty-three pregnant women with HIV (WWH), ages 18–45 and receiving ART, were randomized to a psychosocial depression and adherence intervention or treatment as usual (TAU) to evaluate intervention feasibility, acceptability, and preliminary effect on depressive symptoms and ART adherence. Assessments were conducted pre-, immediately post-, and 3 months post-treatment, and included a qualitative exit interview. Results Most (67.6%) eligible individuals enrolled; 71% completed at least 75% of sessions. Compared to TAU, intervention participants had significantly greater improvements in depressive symptoms at post-treatment, β = − 11.1, t(24) = − 3.1, p < 0.005, 95% CI [− 18.41, − 3.83], and 3 months, β = − 13.8, t(24) = − 3.3, p < 0.005, 95% CI [− 22.50, − 5.17]. No significant differences in ART adherence, social support, or stigma were found. Qualitatively, perceived improvements in social support, self-esteem, and problem-solving adherence barriers emerged as key benefits of the intervention; additional sessions were desired. Conclusion A combined depression and ART adherence intervention appears feasible and acceptable, and demonstrated preliminary evidence of efficacy in a high-need population. Additional research is needed to confirm efficacy and identify dissemination strategies to optimize the health of WWH and their children. Trial Registration ClinicalTrials.gov identifier: NCT03069417. Protocol available at https://clinicaltrials.gov/ct2/show/NCT03069417
- 8 March 2022
- Published by Springer Nature in International Journal of Behavioral Medicine
- Vol. 30 (1) , 62-76
Optimizing PMTCT Adherence by Treating Depression in Perinatal Women with HIV in South Africa: A Pilot Randomized Controlled Trial
Background South Africa (SA) has the greatest HIV prevalence in the world, with rates as high as 40% among pregnant women. Depression is a robust predictor of nonadherence to antiretroviral therapy (ART) and engagement in HIV care; perinatal depression may affect upwards of 47% of women in SA. Evidence-based, scalable approaches for depression treatment and ART adherence in this setting are lacking. Method Twenty-three pregnant women with HIV (WWH), ages 18–45 and receiving ART, were randomized to a psychosocial depression and adherence intervention or treatment as usual (TAU) to evaluate intervention feasibility, acceptability, and preliminary effect on depressive symptoms and ART adherence. Assessments were conducted pre-, immediately post-, and 3 months post-treatment, and included a qualitative exit interview. Results Most (67.6%) eligible individuals enrolled; 71% completed at least 75% of sessions. Compared to TAU, intervention participants had significantly greater improvements in depressive symptoms at post-treatment, β = − 11.1, t(24) = − 3.1, p < 0.005, 95% CI [− 18.41, − 3.83], and 3 months, β = − 13.8, t(24) = − 3.3, p < 0.005, 95% CI [− 22.50, − 5.17]. No significant differences in ART adherence, social support, or stigma were found. Qualitatively, perceived improvements in social support, self-esteem, and problem-solving adherence barriers emerged as key benefits of the intervention; additional sessions were desired. Conclusion A combined depression and ART adherence intervention appears feasible and acceptable, and demonstrated preliminary evidence of efficacy in a high-need population. Additional research is needed to confirm efficacy and identify dissemination strategies to optimize the health of WWH and their children. Trial Registration ClinicalTrials.gov identifier: NCT03069417. Protocol available at https://clinicaltrials.gov/ct2/show/NCT03069417
- Open Access
- 13 October 2021
- Published by JMIR Publications Inc. in JMIR Preprints
Demonstration and Acceptability of a Safer Conception Intervention for Men With HIV in South Africa: Pilot Cohort Study (Preprint)
BACKGROUND Many men with HIV (MWH) want to have children. HIV viral suppression minimizes sexual HIV transmission risks while allowing for conception and optimization of the health of men, their partners, and their infants. OBJECTIVE This study developed and evaluated the feasibility and acceptability of an intervention to promote serostatus disclosure, antiretroviral therapy (ART) uptake and adherence, and viral suppression among MWH who want to have children in South Africa. METHODS We developed a safer conception intervention (Sinikithemba Kwabesilisa or We give hope to men) to promote viral suppression via ART uptake and adherence, HIV serostatus disclosure, and other safer conception strategies for MWH in South Africa. Through 3 counseling and 2 booster sessions over 12 weeks, we offered education on safer conception strategies and aided participants in developing a safer conception plan. We recruited MWH (HIV diagnosis known for >1 month), not yet accessing ART or accessing ART for <3 months, in a stable partnership with an HIV-negative or unknown-serostatus woman, and wanting to have a child in the following year. We conducted an open pilot study to evaluate acceptability based on patient participation and exit interviews and feasibility based on recruitment and retention. In-depth exit interviews were conducted with men to explore intervention acceptability. Questionnaires collected at baseline and exit assessed disclosure outcomes; CD4 and HIV-RNA data were used to evaluate preliminary impacts on clinical outcomes of interest. RESULTS Among 31 eligible men, 16 (52%) enrolled in the study with a median age of 29 (range 27-44) years and a median time-since-diagnosis of 7 months (range 1 month to 9 years). All identified as Black South African, with 56% (9/16) reporting secondary school completion and 44% (7/16) reporting full-time employment. Approximately 44% (7/16) of participants reported an HIV-negative (vs unknown-serostatus) partner. Approximately 88% (14/16) of men completed the 3 primary counseling sessions. In 11 exit interviews, men reported personal satisfaction with session content and structure while also suggesting that they would refer their peers to the program. They also described the perceived effectiveness of the intervention and self-efficacy to benefit. Although significance testing was not conducted, 81% (13/16) of men were taking ART at the exit, and 100% (13/13) of those on ART were virally suppressed at 12 weeks. Of the 16 men, 12 (75%) reported disclosure to pregnancy partners. CONCLUSIONS These preliminary data suggest that safer conception care is acceptable to men and has the potential to reduce HIV incidence among women and their children while supporting men’s health. Approximately half of the men who met the screening eligibility criteria were enrolled. Accordingly, refinement to optimize uptake is needed. Providing safer conception care and peer support at the community level may help reach men. CLINICALTRIAL ClinicalTrials.gov NCT03818984; https://clinicaltrials.gov/ct2/show/NCT03818984 INTERNATIONAL REGISTERED REPORT RR2-https://doi.org/10.1007/s10461-017-1719-4
- 13 October 2021
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessDemonstration and Acceptability of a Safer Conception Intervention for Men With HIV in South Africa: Pilot Cohort Study (Preprint)
BACKGROUND Many men with HIV (MWH) want to have children. HIV viral suppression minimizes sexual HIV transmission risks while allowing for conception and optimization of the health of men, their partners, and their infants. OBJECTIVE This study developed and evaluated the feasibility and acceptability of an intervention to promote serostatus disclosure, antiretroviral therapy (ART) uptake and adherence, and viral suppression among MWH who want to have children in South Africa. METHODS We developed a safer conception intervention (Sinikithemba Kwabesilisa or We give hope to men) to promote viral suppression via ART uptake and adherence, HIV serostatus disclosure, and other safer conception strategies for MWH in South Africa. Through 3 counseling and 2 booster sessions over 12 weeks, we offered education on safer conception strategies and aided participants in developing a safer conception plan. We recruited MWH (HIV diagnosis known for >1 month), not yet accessing ART or accessing ART for <3 months, in a stable partnership with an HIV-negative or unknown-serostatus woman, and wanting to have a child in the following year. We conducted an open pilot study to evaluate acceptability based on patient participation and exit interviews and feasibility based on recruitment and retention. In-depth exit interviews were conducted with men to explore intervention acceptability. Questionnaires collected at baseline and exit assessed disclosure outcomes; CD4 and HIV-RNA data were used to evaluate preliminary impacts on clinical outcomes of interest. RESULTS Among 31 eligible men, 16 (52%) enrolled in the study with a median age of 29 (range 27-44) years and a median time-since-diagnosis of 7 months (range 1 month to 9 years). All identified as Black South African, with 56% (9/16) reporting secondary school completion and 44% (7/16) reporting full-time employment. Approximately 44% (7/16) of participants reported an HIV-negative (vs unknown-serostatus) partner. Approximately 88% (14/16) of men completed the 3 primary counseling sessions. In 11 exit interviews, men reported personal satisfaction with session content and structure while also suggesting that they would refer their peers to the program. They also described the perceived effectiveness of the intervention and self-efficacy to benefit. Although significance testing was not conducted, 81% (13/16) of men were taking ART at the exit, and 100% (13/13) of those on ART were virally suppressed at 12 weeks. Of the 16 men, 12 (75%) reported disclosure to pregnancy partners. CONCLUSIONS These preliminary data suggest that safer conception care is acceptable to men and has the potential to reduce HIV incidence among women and their children while supporting men’s health. Approximately half of the men who met the screening eligibility criteria were enrolled. Accordingly, refinement to optimize uptake is needed. Providing safer conception care and peer support at the community level may help reach men. CLINICALTRIAL ClinicalTrials.gov NCT03818984; https://clinicaltrials.gov/ct2/show/NCT03818984 INTERNATIONAL REGISTERED REPORT RR2-https://doi.org/10.1007/s10461-017-1719-4
- Open Access
- 17 October 2019
- Published by Springer Nature in BMC Health Services Research
- Vol. 19 (1) , 1-11
“As we have gathered with a common problem, so we seek a solution”: exploring the dynamics of a community dialogue process to encourage community participation in family planning/contraceptive programmes
Background: Community dialogues have been widely used as a method for community engagement and participation to cover a broad range of areas. However, there has been limited documentation and evaluation of the process, particularly as a method towards achieving family planning and contraception (FP/C) programme goals. As part of the development of an intervention package aimed at increasing community and health care provider (HCP) participation in the provision of FP/C, feasibility testing of the intervention approach (a community dialogue between communities and health facilities) was carried out. Our findings offer a systematic description and evaluation of the community dialogue process, with key recommendations towards future implementation. Methods: The dialogue was evaluated in three ways: 1) through participant observation during the community dialogue, 2) via a standardised feasibility testing tick-list for all observers of the dialogue, and 3) through three focus group discussions (FGDs) consisting of different groups of stakeholders who participated in the community dialogue. In total, 28 community members, HCPs, and key stakeholders attended the community dialogue (22 females, 6 males). Twenty-seven of the community dialogue participants participated in one of 3 FGDs held after the dialogue. Six evaluators assessed feasibility of the dialogue process. Results: There was good attendance, representation and participation amongst community and provider sectors based on the participant observations using the standardized feasibility check-list. The community dialogue process received positive feedback in the FGDs and was demonstrated to be feasible and acceptable. Key factors contributing to the success of the community dialogue included a skilled facilitator, good representation of participants, establishing ground rules, good timekeeping, and using a Theory of Change to facilitate goal identification and dialogue. Issues to consider are the underlying power differentials related to age, profession and gender which caused initial feelings of anxiety amongst some participants. Conclusions: Our formative findings offer a systematic description and evaluation of a community dialogue process with key recommendations that may be considered when constituting similar community dialogues in the future.
- 17 October 2019
- Published by Springer Nature in BMC Health Services Research
- Vol. 19 (1) , 1-11
Open Access“As we have gathered with a common problem, so we seek a solution”: exploring the dynamics of a community dialogue process to encourage community participation in family planning/contraceptive programmes
Background: Community dialogues have been widely used as a method for community engagement and participation to cover a broad range of areas. However, there has been limited documentation and evaluation of the process, particularly as a method towards achieving family planning and contraception (FP/C) programme goals. As part of the development of an intervention package aimed at increasing community and health care provider (HCP) participation in the provision of FP/C, feasibility testing of the intervention approach (a community dialogue between communities and health facilities) was carried out. Our findings offer a systematic description and evaluation of the community dialogue process, with key recommendations towards future implementation. Methods: The dialogue was evaluated in three ways: 1) through participant observation during the community dialogue, 2) via a standardised feasibility testing tick-list for all observers of the dialogue, and 3) through three focus group discussions (FGDs) consisting of different groups of stakeholders who participated in the community dialogue. In total, 28 community members, HCPs, and key stakeholders attended the community dialogue (22 females, 6 males). Twenty-seven of the community dialogue participants participated in one of 3 FGDs held after the dialogue. Six evaluators assessed feasibility of the dialogue process. Results: There was good attendance, representation and participation amongst community and provider sectors based on the participant observations using the standardized feasibility check-list. The community dialogue process received positive feedback in the FGDs and was demonstrated to be feasible and acceptable. Key factors contributing to the success of the community dialogue included a skilled facilitator, good representation of participants, establishing ground rules, good timekeeping, and using a Theory of Change to facilitate goal identification and dialogue. Issues to consider are the underlying power differentials related to age, profession and gender which caused initial feelings of anxiety amongst some participants. Conclusions: Our formative findings offer a systematic description and evaluation of a community dialogue process with key recommendations that may be considered when constituting similar community dialogues in the future.